Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Guo-Kai Shang"'
Autor:
Sen‐bo Yan, Huan Liang, Peng Zhan, Hui Zheng, Qin‐xiao Zhao, Zi‐jie Zheng, Hui‐xia Lu, Guo‐kai Shang, Xiao‐ping Ji
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 6, Pp 2623-2641 (2023)
Abstract Background Declined skeletal muscle mass and function are inevitable consequences of long‐term diabetes and bring about many adverse events. Muscle fibre atrophy and interstitial fibrosis are major pathological manifestations of diabetic s
Externí odkaz:
https://doaj.org/article/34db39bd243748afb87dd60d4b038350
Autor:
Guo‐kai Shang, Lu Han, Zhi‐hao Wang, Ming Song, Di Wang, Yan‐min Tan, Yi‐hui Li, Yu‐lin Li, Wei Zhang, Ming Zhong
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1741-1756 (2021)
Abstract Background Sarcopenia widely exists in elderly people and triggers numerous age‐related events. The essential pathologic change lies in the increased intramuscular adipose tissue after aging with no exception to non‐obese objects. Pim1 a
Externí odkaz:
https://doaj.org/article/a5e9e5cad6de403c8051d6d431c0652e
Autor:
Guo‐Kai Shang, Lu Han, Zhi‐Hao Wang, Ya‐Peng Liu, Sen‐Bo Yan, Wen‐Wen Sai, Di Wang, Yi‐Hui Li, Wei Zhang, Ming Zhong
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Abstract Background Sarcopenia causes several adverse events in elderly people. Muscle fibre atrophy and interstitial fibrosis are the main histopathological changes in sarcopenia and account for decreased muscle function. Tribbles homologue 3 (TRB3)
Externí odkaz:
https://doaj.org/article/08db9debcc474069a576334d59b5af8f
Autor:
Di Wang, Ming Song, Long-fei Shen, Lu Han, Ping Zhu, Xu Jia, Guo-kai Shang, Yuan Cao, Wei Zhang, Ming Zhong, Zhi-hao Wang
Publikováno v:
Frontiers in Physiology, Vol 12 (2022)
BackgroundPatients suffering from chronic heart failure (CHF) show an increased prevalence of sarcopenia. Levosimendan is an effective drug for the treatment of heart failure, but its effect on sarcopenia is still unclear. We aimed to explore whether
Externí odkaz:
https://doaj.org/article/e5fc78e0012240ccbdf531dde65cbd64
Autor:
Ming Song, Guo-Kai Shang, Wei Zhang, Ming Zhong, Yulin Li, Yi-Hui Li, Lu Han, Zhi-Hao Wang, Yan-Min Tan, Di Wang
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1741-1756 (2021)
Background Sarcopenia widely exists in elderly people and triggers numerous age‐related events. The essential pathologic change lies in the increased intramuscular adipose tissue after aging with no exception to non‐obese objects. Pim1 appears to
Autor:
Guo-Kai Shang, Xiaomei Chen, Hui-Min Zhou, Qiang Sun, Fang-Fang Chen, Wei Zhang, Ming Zhong, Yi-Hui Li, Hao Wang, Chen Li, Dawei Wu, Juan Du, Shifang Ding, Zhi-Hao Wang, Feng Wang, Yirui Liu
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:1535-1546
Objectives Currently there is no validated method to predict renal reversal and recovery after acute kidney injury (AKI). As exosomes have the potential for AKI prognosis and CD26 is involved in the mechanisms in AKI, this study aims to investigate w
Autor:
Lu Han, Wei Zhang, Yi-Hui Li, Ya-Peng Liu, Zhi-Hao Wang, Ming Zhong, Di Wang, Guo-Kai Shang, Sen-bo Yan, Wen-Wen Sai
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1104-1120 (2020)
Background Sarcopenia causes several adverse events in elderly people. Muscle fibre atrophy and interstitial fibrosis are the main histopathological changes in sarcopenia and account for decreased muscle function. Tribbles homologue 3 (TRB3) was prev
Autor:
Di Wang, Ming Song, Long-fei Shen, Lu Han, Ping Zhu, Xu Jia, Guo-kai Shang, Yuan Cao, Wei Zhang, Ming Zhong, Zhi-hao Wang
Publikováno v:
Frontiers in Physiology
Frontiers in Physiology, Vol 12 (2022)
Frontiers in Physiology, Vol 12 (2022)
BackgroundPatients suffering from chronic heart failure (CHF) show an increased prevalence of sarcopenia. Levosimendan is an effective drug for the treatment of heart failure, but its effect on sarcopenia is still unclear. We aimed to explore whether
Autor:
Wei Zhang, Di Wang, Zhi-Hao Wang, Ming Song, Xu Jia, Ping Zhu, Ming Zhong, Yuan Cao, Lu Han, Long-fei Shen, Guo-Kai Shang
Background Sarcopenia, a common complication of heart failure (HF), dramatically reduces the benefits of exercise training. Levosimendan is an effective drug for the treatment of heart failure, but its relationship with sarcopenia is still unclear. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c20256dd76378fa7aa6935229d63ed6f
https://doi.org/10.21203/rs.3.rs-617003/v1
https://doi.org/10.21203/rs.3.rs-617003/v1
Autor:
Fang-Fang Chen, Wei Zhang, Ming Song, Ming Zhong, Lu Han, Guo-Kai Shang, Ya Li, Zhi-Hao Wang, Di Wang, Yulin Li, Hui-Min Zhou
Publikováno v:
Journal of Cellular and Molecular Medicine
Diabetic nephropathy (DN) is a chronic inflammatory disease triggered by disordered metabolism. Recent studies suggested that protein tyrosine phosphatase non‐receptor type 2 (PTPN2) could ameliorate metabolic disorders and suppress inflammatory re